MFDS — authorised 8 November 2001
- Marketing authorisation holder: ENDO PHARMS
- Status: likely_approved
🇰🇷 Frova in South Korea
MFDS authorised Frova on 8 November 2001
Marketing authorisation
Frova in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Frova approved in South Korea?
Yes. MFDS authorised it on 8 November 2001.
Who is the marketing authorisation holder for Frova in South Korea?
ENDO PHARMS holds the South Korean marketing authorisation.